|
Volumn 34, Issue 2, 1978, Pages 151-156
|
Oral contraceptives, blood clotting and thrombosis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BLOOD CLOTTING FACTOR;
GESTAGEN;
ORAL CONTRACEPTIVE AGENT;
ADVERSE DRUG REACTION;
BLOOD CLOTTING;
ESTROGEN THERAPY;
FIBRINOLYSIS;
ORAL DRUG ADMINISTRATION;
REVIEW;
SURVEY;
THROMBOCYTE;
THROMBOGENESIS;
VEIN THROMBOSIS;
BIOLOGY;
BLOOD COAGULATION EFFECTS;
CONTRACEPTION;
CONTRACEPTIVE AGENTS, ESTROGEN;
CONTRACEPTIVE AGENTS, PROGESTIN;
CONTRACEPTIVE METHODS--SIDE EFFECTS;
DISEASES;
EMBOLISM;
FAMILY PLANNING;
FIBRINOLYSIS;
HEMATOLOGICAL EFFECTS;
HEMIC SYSTEM;
ORAL CONTRACEPTIVES--SIDE EFFECTS;
PHYSIOLOGY;
PLATELET AGGREGATION;
THROMBOEMBOLISM;
THROMBOSIS;
VASCULAR DISEASES;
ANTITHROMBINS;
BLOOD COAGULATION;
BLOOD COAGULATION FACTORS;
BLOOD COAGULATION TESTS;
BLOOD PLATELETS;
CONTRACEPTIVES, ORAL;
ESTROGENS;
FEMALE;
FIBRIN FIBRINOGEN DEGRADATION PRODUCTS;
FIBRINOGEN;
FIBRINOLYSIS;
HUMAN;
PROGESTATIONAL HORMONES;
THROMBOSIS;
|
EID: 0018138186
PISSN: 00071420
EISSN: None
Source Type: Journal
DOI: 10.1093/oxfordjournals.bmb.a071485 Document Type: Article |
Times cited : (105)
|
References (74)
|